The meeting of the National Vaccination Committee was completed, which unanimously decided to administer the AstraZeneca vaccine to citizens up to 64 years old, confirming the report of iefimerida.gr .
The meeting was followed by statements by the President of the National Vaccination Committee Maria Theodoridou and the Secretary General of Primary Health Care Marios Themistokleous.
“The National Vaccination Committee has reviewed in detail all available data on the safety and efficacy of the Oxford / AstraZeneca vaccine , following the recent approval of the vaccine by the European Medicines Agency for use in persons 18 years of age and older and with a view to its availability. in Greece in the near future “, said Maria Theodoridou in quotes.
“The Commission considers that, according to the data available to date, the AstraZeneca vaccine has very good safety, immunogenicity, and efficacy characteristics.
a) It is safe, well tolerated by people taking it and the side effects are mostly mild and local.
b) It protects almost all those vaccinated from a serious illness and from the need to be admitted to the hospital, while it protects a large part of those vaccinated from a mild illness.
c) It generates high antibody responses in people of all ages, including the elderly, and in addition causes strong stimulation of cellular immunity, which is an essential part of immunization.
d) It seems to reduce virulence in vaccinated individuals who may be infected by their environment and therefore helps to limit the spread of the virus.
Regarding the protection, ie the effectiveness, from serious and mild disease, it is noted that the number of elderly people who are currently included in the published studies is relatively small, so there is no strong scientific evidence for older people. However, based on the data available on the immunogenicity of the vaccine at all ages, it is estimated that protection is likely to affect older people as well.
Regarding the interval between the first and second dose of the vaccine, according to the available data, the interval of 12 weeks creates higher levels of final protection compared to shorter intervals.
- The National Vaccination Committee recommends vaccination with the AstraZeneca vaccine for people aged 18 to 64 years.
- The National Vaccination Committee recommends a 12-week interval between the first and second dose of the vaccine.
- These recommendations may be amended in the near future, depending on the latest data. “
Themistocleous: Vaccinations start after February 12
“We have the decision of the National Vaccination Committee, which gives us the green light to carry out vaccinations with the AstraZeneca vaccine in our country. In Greece, as in other European Union countries, the AstraZeneca vaccine will be used for those aged 18-64
Before I start with the operational ones, I would like to state very clearly that it is a vaccine of exceptional effectiveness. The only reason for this decision is that there are insufficient data on the ages over 65, which are expected in the coming days. Let me remind you that very large countries, such as the United Kingdom and the United States, have already vaccinated thousands of people and people over the age of 65. And since we will have the effectiveness of the vaccine in these groups by the end of the month, then we are expected to change this decision as well.
Operationally, we will develop two parallel systems.
The 1st system is what we have at the moment and next to it will open a 2nd that relates to the vaccination with the vaccine of AstraZeneca, a first age group will open for these vaccinations will be 60-64.
The two systems will not intersect. That is, a citizen over the age of 80 will be able to make an appointment only at specific vaccination centers, while citizens aged 60-64 will be able to make an appointment only at the vaccination centers with AstraZeneca vaccines and not at the vaccination centers of the other categories. .
Vaccinations with the AstraZeneca vaccine are expected to begin after 12 February. The platform will open in the coming days.
The specific dates will be announced on Monday, when the delivery plan has been finalized by the company. “Operationally, we are fully prepared for the implementation of this strategy”, noted in his statements the General Secretary of Primary Health Care, Marios Themistokleous.